Sign in
4

Changes in Ownership

Nuvectis Pharma, Inc. Filed Acc 0001104659-22-103162

Chairman & CEO bought 1,500 shares at an average $7.85 ($11,775)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
BENTSUR RON Chairman & CEO 2022-09-23 Purchase +1,000 $7.93 $7,930 3,011,609 D: show line 1 in the form
BENTSUR RON Chairman & CEO 2022-09-26 Purchase +500 $7.69 $3,845 3,012,109 D: show line 2 in the form
Open-market purchases · 1,500 sh · avg $7.85 · $11,775
Loading xslF345X03/tm2226689-1_4seq1.xml…